Nanoparticles as an effective drug delivery system in COVID-19

BACKGROUND: The global healthcare sector has been dealing with a situation known as a novel severe acute respiratory syndrome (SARS-CoV-2) since the end of 2019. Covid-19 is an acronym for Covid-19 (Coronavirus Disease- 2019). It causes a respiratory infection that includes cold, sneezing and coughi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chowdhury, Neehasri Kumar, Deepika, Choudhury, Reshma, Sonawane, Gaurav Ambadas, Mavinamar, Shankar, Lyu, Xiaoming, Pandey, Ramendra Pati, Chang, Chung-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Masson SAS. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426213/
https://www.ncbi.nlm.nih.gov/pubmed/34649334
http://dx.doi.org/10.1016/j.biopha.2021.112162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426213/
https://www.ncbi.nlm.nih.gov/pubmed/34649334
http://dx.doi.org/10.1016/j.biopha.2021.112162

Ejemplares similares